EUVIMEDEUVIMED entdecken
Crossref

Clinician’s Perspectives on the use of Vildagliptin and its Fixed-Dose Combination with Metformin in the Management of Type 2 Diabetes Mellitus in India

S Manjula

Advances in Diabetes & Endocrinology · 2025

DOI: 10.13188/2475-5591.1000020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Diabetes & Endocrinology, 2025. Verfasst von S Manjula.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

in the initiation and management of pharmacotherapy for T2DM, with a particular focus on the role of vildagliptin and its fixed-dose combination (FDC) with metformin.

Zitieren

APA

Manjula, S. (2025). Clinician’s Perspectives on the use of Vildagliptin and its Fixed-Dose Combination with Metformin in the Management of Type 2 Diabetes Mellitus in India. Advances in Diabetes & Endocrinology. https://doi.org/10.13188/2475-5591.1000020

Vancouver

Manjula S. Clinician’s Perspectives on the use of Vildagliptin and its Fixed-Dose Combination with Metformin in the Management of Type 2 Diabetes Mellitus in India. Advances in Diabetes & Endocrinology. 2025. doi:10.13188/2475-5591.1000020

BibTeX
@article{Manjula2025,
  author = {Manjula, S},
  title = {Clinician’s Perspectives on the use of Vildagliptin and its Fixed-Dose Combination with Metformin in the Management of Type 2 Diabetes Mellitus in India},
  journal = {Advances in Diabetes & Endocrinology},
  year = {2025},
  doi = {10.13188/2475-5591.1000020}
}
Kostenlos starten →